On this page:

 Chimeric Antigen Receptor T- Cell Therapy (CAR-T) is a treatment pathway currently for patients with certain types of blood cancer. 

It is a treatment that consists of taking a certain type of immune system cell, which is then modified and given back to the patient. The aim is to use the body’s immune system to treat their disease. 

For more information and detail on CAR-T Therapy please click on the following links: 

HAE_CART.pdf 

CAR-T cell therapy | Lymphoma Action 

CAR T-cell therapy – Leukaemia Care 

What is CAR T-cell therapy? | Anthony Nolan 

Nominate your NHS hero for a gesh CARE award

Who deserves recognition? Nominate them today.

Have you or a loved one received outstanding care from St George’s, Epsom and St Helier Hospitals, Sutton Health and Care, or Surrey Downs Health and Care? 

For many colleagues, being nominated for our staff awards is just as meaningful as winning. Your words help us recognise and celebrate the people who make outstanding care possible every day. 

Submit your nomination before 19 July and help us celebrate the people behind outstanding care.